Back to top
more

Elite Pharmaceuticals (ELTP)

(Delayed Data from OTC)

$0.50 USD

0.50
1,948,352

+0.06 (13.18%)

Updated Nov 1, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Income Statements

Fiscal Year end for Elite Pharmaceuticals Inc falls in the month of March .

All items in Millions except EPS data.

3/31/24 3/31/23 3/31/22 3/31/21 3/31/20
Sales 57 34 32 25 18
Cost Of Goods 30 18 17 14 10
Gross Profit 26 17 15 12 8
Selling & Adminstrative & Depr. & Amort Expenses 16 13 10 10 10
Income After Depreciation & Amortization 11 4 5 2 -2
Non-Operating Income -10 1 1 2 0
Interest Expense 1 1 0 0 0
Pretax Income 0 4 6 4 -2
Income Taxes -20 0 -2 -1 0
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 1 0 0
Income From Cont. Operations 20 4 9 5 -2
Extras & Discontinued Operations 0 0 0 0 0
Net Income (GAAP) 20 4 9 5 -2
Depreciation Footnote 3/31/24 3/31/23 3/31/22 3/31/21 3/31/20
Income Before Depreciation & Amortization 12 5 7 4 -1
Depreciation & Amortization (Cash Flow) 1 1 1 2 2
Income After Depreciation & Amortization 11 4 5 2 -2
Earnings Per Share Data 3/31/24 3/31/23 3/31/22 3/31/21 3/31/20
Average Shares 1,023.23 1,012.91 1,010.61 943.00 993.26
Diluted EPS Before Non-Recurring Items 0.03 0.00 0.01 0.01 0.00
Diluted Net EPS (GAAP) 0.02 0.00 0.01 0.01 0.00

Fiscal Year end for Elite Pharmaceuticals Inc falls in the month of March .

All items in Millions except EPS data.

9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
Sales NA 18.80 17.95 15.54 14.16
Cost Of Goods NA 10.33 9.83 8.50 7.71
Gross Profit NA 8.47 8.12 7.04 6.45
SG&A, R&D, and Dept/Amort Expenses 0.00 4.61 4.39 3.50 4.53
Income After SG&A, R&D, and Dept/Amort Expenses 0.00 3.86 3.73 3.54 1.92
Non-Operating Income NA -2.77 -1.52 -3.51 -4.53
Interest Expense NA 0.25 0.22 0.12 0.13
Pretax Income NA 0.85 1.99 -0.09 -2.73
Income Taxes NA 0.23 -1.33 -0.80 -17.67
Minority Interest NA 0.00 0.00 0.00 0.00
Investment Gains/Losses NA 0.00 0.00 0.00 0.00
Other Income/Charges NA 0.00 0.00 0.00 0.00
Income From Cont. Operations NA 0.62 3.33 0.71 14.93
Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
Net Income (GAAP) NA 0.62 3.33 0.71 14.93
Earnings Per Share Data 9/30/24 6/30/24 3/31/24 12/31/23 9/30/23
Average Shares NA 1,076.25 1,042.39 1,024.45 1,019.32
Diluted EPS Before Non-Recurring Items NA 0.00 0.00 0.00 0.01
Diluted Net EPS (GAAP) NA 0.00 0.01 0.00 0.01